ZA926310B - Pharmaceuticals for the treatment of rejection reactions in organ transplantations - Google Patents

Pharmaceuticals for the treatment of rejection reactions in organ transplantations

Info

Publication number
ZA926310B
ZA926310B ZA926310A ZA926310A ZA926310B ZA 926310 B ZA926310 B ZA 926310B ZA 926310 A ZA926310 A ZA 926310A ZA 926310 A ZA926310 A ZA 926310A ZA 926310 B ZA926310 B ZA 926310B
Authority
ZA
South Africa
Prior art keywords
treatment
pharmaceuticals
rejection reactions
organ transplantations
organ
Prior art date
Application number
ZA926310A
Other languages
English (en)
Inventor
Robert Ryder Bartlett
Ryder Bartlett Robert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA926310B publication Critical patent/ZA926310B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
ZA926310A 1991-08-22 1992-08-21 Pharmaceuticals for the treatment of rejection reactions in organ transplantations ZA926310B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4127737A DE4127737A1 (de) 1991-08-22 1991-08-22 Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen

Publications (1)

Publication Number Publication Date
ZA926310B true ZA926310B (en) 1993-04-28

Family

ID=6438804

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA926310A ZA926310B (en) 1991-08-22 1992-08-21 Pharmaceuticals for the treatment of rejection reactions in organ transplantations

Country Status (18)

Country Link
US (3) US5728721A (enExample)
EP (1) EP0529500B1 (enExample)
JP (1) JP3285226B2 (enExample)
KR (1) KR100253450B1 (enExample)
AT (1) ATE113835T1 (enExample)
AU (1) AU654031B2 (enExample)
CA (1) CA2076555C (enExample)
CZ (1) CZ281353B6 (enExample)
DE (2) DE4127737A1 (enExample)
DK (1) DK0529500T3 (enExample)
ES (1) ES2065738T3 (enExample)
HU (1) HU219402B (enExample)
IL (1) IL102886A (enExample)
MX (1) MX9204875A (enExample)
RU (1) RU2067862C1 (enExample)
SK (1) SK279323B6 (enExample)
TW (1) TW210284B (enExample)
ZA (1) ZA926310B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4127737A1 (de) 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
US5624946A (en) * 1994-07-05 1997-04-29 Williams; James Use of leflunomide to control and reverse chronic allograft rejection
PT787491E (pt) * 1994-10-17 2000-11-30 Aventis Pharma Ltd Composicao para a profilaxia e para o tratamento de doencas alergicas de tipo i
DE19547648A1 (de) * 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
DE19610955A1 (de) 1996-03-20 1997-09-25 Hoechst Ag Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
ATE207065T1 (de) * 1997-08-08 2001-11-15 Aventis Pharma Gmbh Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid
DE19857009A1 (de) * 1998-12-10 2000-06-15 Aventis Pharma Gmbh Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren
DE19908527C2 (de) * 1999-02-26 2001-08-30 Aventis Pharma Gmbh Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
FR2802101B1 (fr) 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
DE19960443C2 (de) * 1999-12-15 2002-05-08 Aventis Pharma Gmbh Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen
WO2003039231A2 (en) * 2001-10-25 2003-05-15 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
WO2005011669A1 (ja) * 2003-08-05 2005-02-10 Dainippon Sumitomo Pharma Co., Ltd. 経皮投与用医薬組成物
US20060024376A1 (en) * 2004-07-30 2006-02-02 The University Of Chicago Methods and compositions for reducing toxicity associated with leflunomide treatment
DE102005017592A1 (de) * 2005-04-16 2006-10-19 Lindner, Jürgen, Dr. med. Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem
CN105272882B (zh) * 2014-07-23 2019-05-31 欣凯医药化工中间体（上海）有限公司 一种环保简便制备泰瑞米特的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2436263C2 (de) 1974-07-27 1983-02-17 Hoechst Ag, 6000 Frankfurt Thiazolidinderivate und Verfahren zu ihrer Herstellung
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
NL178596C (nl) 1975-06-05 1986-04-16 Hoechst Ag Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden.
DE2854439A1 (de) 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
GB8320969D0 (en) * 1983-08-03 1983-09-07 Ici Plc Transparent sheet
DE3405727A1 (de) 1984-02-17 1985-08-22 Hoechst Ag, 6230 Frankfurt Isoxazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5268382A (en) 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5100899A (en) 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
DE4101324A1 (de) 1991-01-18 1992-07-23 Hoechst Ag Isoxazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4127737A1 (de) 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
EP0538783B1 (de) 1991-10-23 1995-09-27 Hoechst Aktiengesellschaft N-phenyl-2-cyano-3-hydroxycrotonsäureamidderivate und deren Verwendung als Arzneimittel mit immunmodulatorischer Eigenschaft
US5624946A (en) * 1994-07-05 1997-04-29 Williams; James Use of leflunomide to control and reverse chronic allograft rejection
US6223209B1 (en) * 1997-09-30 2001-04-24 Ncr Corporation Distributed world wide web servers

Also Published As

Publication number Publication date
SK258292A3 (en) 1995-09-13
SK279323B6 (sk) 1998-10-07
EP0529500A1 (de) 1993-03-03
EP0529500B1 (de) 1994-11-09
US20050080118A1 (en) 2005-04-14
HUT64845A (en) 1994-03-28
KR930003915A (ko) 1993-03-22
JPH05208909A (ja) 1993-08-20
HU219402B (hu) 2001-04-28
US6288098B1 (en) 2001-09-11
JP3285226B2 (ja) 2002-05-27
DE4127737A1 (de) 1993-02-25
TW210284B (enExample) 1993-08-01
AU654031B2 (en) 1994-10-20
DE59200773D1 (de) 1994-12-15
CZ258292A3 (en) 1993-03-17
ES2065738T3 (es) 1995-02-16
US5728721A (en) 1998-03-17
CA2076555A1 (en) 1993-02-23
MX9204875A (es) 1993-02-01
US7402601B2 (en) 2008-07-22
AU2124792A (en) 1993-02-25
RU2067862C1 (ru) 1996-10-20
CA2076555C (en) 2003-07-29
KR100253450B1 (ko) 2000-07-01
DK0529500T3 (da) 1995-04-18
ATE113835T1 (de) 1994-11-15
IL102886A0 (en) 1993-01-31
CZ281353B6 (cs) 1996-09-11
IL102886A (en) 1996-01-19

Similar Documents

Publication Publication Date Title
IL102886A0 (en) Pharmaceuticals for the treatment of rejection reactions in organ transplantations
GR3025658T3 (en) Contrast media for ultrasonic imaging
ZA918126B (en) Di(aromatic)compounds and their use in human and veterinary medicine and in cosmetics
KR0140155B1 (en) Fomentation containing ketorolac
AU5670690A (en) Lysolecithin derivatives for treating autoimmune diseases
EP0572635A4 (fr) Nouveaux composes a structure guanidique et composition pharmaceutique les contenant.
EP0242666B1 (en) Defoliating agent containing thiadiazolyl urea
IL82147A (en) Substituted oxime-ethers,their preparation and their use for controlling plant growth
AU2721592A (en) N-phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property
LTIP1733A (en) Novel bicyclic amino-substituted compounds, process for their preparation and pharmaceutical preparation
GR3005254T3 (enExample)
GR3002486T3 (en) Substituted 5-amino-pyrazoles and fungicides containing them
DE3882381D1 (enExample)
ZA796789B (en) Novel 3,4-diaza-bicyclo (4.1.0) hept-2-en-5-ones, their preparation, and therapeutic agents containing these compounds
HUT70424A (en) Disulfonyl methane derivatives against parasites and pharmaceutical compositions containing such compounds
HU892146D0 (en) Process for the preparation of heteroaromatic compounds containing five-membered ring with nitrogen atom
DE59409645D1 (en) Substituierte arylthioalkylthiopyridine
EP0317913A3 (en) Di(meth)acrylates, process for their preparation and their use
IL84093A0 (en) Aralkyl-4h-1,2,4-triazole derivatives
PH24258A (en) Substituted quinoxyalyl-imidazolidine-2,4-diones,their use as medicaments and pharmaceutical preparation
IL92342A0 (en) Acrylic esters and their use as fungicides
IN172911B (enExample)
ZA822193B (en) 5,6-dihydro-11-alkylene-morphanthridin-6-ones,their preparation,and drugs containing these compounds
PL300522A1 (en) Drugs containing 1,5,6,7-tetrahydro-4h-indasol-4-ones, novel 1,5,6,7-tetrahydro-4h-indasol-4-ones and methods of obtaining sames
ATE89551T1 (de) Verfahren zur herstellung von optisch aktiven acyloxyazetidinonen.